Annie Bauzon: HbA1c Insights and Clinical Importance in Diabetes Management
Annie Bauzon, Medical Laboratory Assistant Technician at Med Health Laboratories, shared a post on LinkedIn:
“Hemoglobin A1c
Hemoglobin A1c (HbA1c), also known as glycated hemoglobin, is a form of hemoglobin that is chemically bound to glucose. It is formed through a non-enzymatic process called glycation, where circulating glucose in the blood attaches to the beta chains of hemoglobin inside red blood cells.
Because red blood cells have an average lifespan of approximately 120 days, the HbA1c level reflects the average blood glucose concentration over the previous 2–3 months rather than the glucose level at a single point in time.
This makes HbA1c a reliable long-term indicator of glycemic control.
HbA1c is widely used in the diagnosis and monitoring of Diabetes mellitus.
According to international diagnostic criteria:
- HbA1c value below 5.7% is considered normal.
- Between 5.7% and 6.4% indicates prediabetes, which reflects increased risk for developing diabetes.
- HbA1c level of 6.5% or higher on two separate tests is diagnostic of diabetes.
In individuals already diagnosed with diabetes, HbA1c is used to assess how well blood glucose has been controlled over time.
For many non-pregnant adults with diabetes, a common treatment target is an HbA1c below 7%, although targets may vary depending on age, comorbidities, and risk of hypoglycemia.
The clinical importance of HbA1c lies in its strong association with long-term complications of chronic hyperglycemia.
Persistently elevated HbA1c levels are linked to:
- microvascular complications: diabetic retinopathy, nephropathy, and neuropathy.
- macrovascular complications: cardiovascular disease and stroke.
Studies have demonstrated that lowering HbA1c significantly reduces the risk of these complications, highlighting the importance of strict glycemic control.
One advantage of the HbA1c test is that it does not require fasting and is not significantly affected by short-term stress or recent meals.
However, certain conditions can influence the accuracy of HbA1c results.
Disorders affecting red blood cell turnover, such as hemolytic anemia, recent blood loss, or hemoglobinopathies (e.g., sickle cell disease), may produce falsely low or high values. Chronic kidney disease and iron deficiency anemia can also alter results. Therefore, clinical context must always be considered when interpreting HbA1c levels.
In summary, HbA1c is a crucial biochemical marker that provides an integrated measure of long-term blood glucose control.
It plays a central role:
- Diagnosing diabetes
- Identifying individuals at high risk,
- Guiding therapeutic decisions, and
- Predicting complications.
Proper interpretation of HbA1c values, combined with clinical assessment and other laboratory findings, is essential for optimal management of patients with glucose metabolism disorders.”
Stay updated with Hemostasis Today.
-
Mar 13, 2026, 12:41Ifeanyichukwu Ifechidere: Anaemia is not a Diagnosis – It’s a Symptom
-
Mar 13, 2026, 12:18Abdallah Othman: Arterial Blood Supply of the Cardiac Conduction System
-
Mar 13, 2026, 12:14Roshni Kulkarni: Honoring Women and Girls Living With Bleeding Disorders
-
Mar 13, 2026, 11:48Kausik Ray: Efficacy and Safety of Obicetrapib in Patients With HeFH on Maximally Tolerated Statins
-
Mar 13, 2026, 11:36Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
-
Mar 13, 2026, 10:28Anupama Ariyasiri։ A Systematic Review of Transfusion Strategies in Neurocritical Care
-
Mar 13, 2026, 10:08Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
-
Mar 13, 2026, 10:00Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH